Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Widschwendter

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Oncogene|May 27, 2014
Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpointsS V del Rincón, M Widschwendter, D Sun, et al.
British Journal of Cancer|June 4, 2009
Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle studyM Widschwendter, H Lichtenberg-Frate, G Hasenbrink, et al.
British Journal of Cancer|November 24, 2011
Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patientsG Goebel, R Berger, A M Strasak, et al.
Gynecologic Oncology|September 9, 2022
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safeW L Van der Kolk, A G J Van der Zee, B M Slomovitz, et al.
British Journal of Cancer|October 29, 2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyM Köbel, J Madore, S J Ramus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Oncogene|May 27, 2014
Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpointsS V del Rincón, M Widschwendter, D Sun, et al.
British Journal of Cancer|June 4, 2009
Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle studyM Widschwendter, H Lichtenberg-Frate, G Hasenbrink, et al.
British Journal of Cancer|November 24, 2011
Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patientsG Goebel, R Berger, A M Strasak, et al.
Gynecologic Oncology|September 9, 2022
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safeW L Van der Kolk, A G J Van der Zee, B M Slomovitz, et al.
British Journal of Cancer|October 29, 2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyM Köbel, J Madore, S J Ramus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 6